NEOGEN (ANIMAL BIOSECURITY DIVISION) acquired by KERSIA
Context
Kersia is acquiring the animal biosecurity cleaners and disinfectants business from Neogen® through an exclusive agreement. This strategic transaction marks a major entry for the French group into the North American swine and poultry markets, complementing its existing domestic presence in the ruminant sector. The acquisition is a transformative step for the group, doubling its American activity and positioning it among the top three global players in the agricultural hygiene and disinfection market. The strategy focuses on leveraging the target's extensive product registration portfolio and its three dedicated U.S. manufacturing sites to provide nationwide coverage. This deal also expands the acquirer's international footprint into 20 new countries, particularly in Central America and the Asia-Pacific region, supporting its ambition to become the undisputed global leader in animal biosecurity.
NEOGEN (ANIMAL BIOSECURITY DIVISION), which reported an EBITDA margin of in 2024, is valued in this transaction at an EV/EBITDA multiple of , a level to compare with the average currently observed in the Healthcare & Pharma sector (14.3x).
-> Deep-dive in Healthcare & Pharma market trends
Target
Neogen's Animal Biosecurity Division is a major North American division specializing in cleaners and disinfectants for the animal biosecurity market. It is a key player in the swine and poultry sectors, providing specialized hygiene and water treatment solutions. With over 120 employees and an international presence in more than 50 countries—including China, Mexico, Brazil, and Australia—the business holds an extensive portfolio of product registrations and certifications. It operates two strategic manufacturing sites in the United States: one in Memphis (Tennessee), located in the heart of the poultry belt, and another in Turlock (California). The division is recognized for its high-quality biosecurity protocols and critical role in preventing contamination within the livestock industry.
Ent. Value
Equity Value
Multiples
EV / Revenue
EV / EBITDA
EV / EBIT
Historical Financials (EUR)
Similar deals in Healthcare Services
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 10/2025 | EVOLEM | APPERTON | FRANCE | Sterilization & Hygiene |
| 05/2025 | FIVE ARROWS | HUBLO | FRANCE | Health Tech |
| 04/2025 | TRANSCARENT | ACCOLADE | UNITED STATES | Health Tech |
| 10/2024 | Fullscript | Rupa Health | UNITED STATES | Health Tech |
| 07/2024 | ARDIAN | MASCO GROUP | ITALY | Healthcare Services |
| 06/2024 | PERMIRA | PHARMACORD | UNITED STATES | Health Tech |
| 05/2024 | 21 INVEST / OAKLEY CAPITAL INVESTMENTS | PRODUCT LIFE | FRANCE | Healthcare Services |
| 10/2023 | MOTION EQUITY PARTNERS | BANOOK | FRANCE | CRO / Clinical Trials |
| 09/2023 | CERBA HEALTHCARE | CIRION BIOPHARMA RESEARCH | CANADA | CRO / Clinical Trials |
| 09/2023 | PERMIRA | ERGOMED | UNITED KINGDOM | CRO / Clinical Trials |
REFERENCES
Valuation range: EV 100M - 350M EUR
Revenue range: 50M - 100M EUR
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of NEOGEN (ANIMAL BIOSECURITY DIVISION) by KERSIA are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Press release: view release
Acquirer: kersia